|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Center MM, Jemal A and Ward E:
International trends in colorectal cancer incidence rates. Cancer
Epidemiol Biomarkers Prev. 18:1688–1694. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Center MM, Jemal A, Smith RA and Ward E:
Worldwide variations in colorectal cancer. CA Cancer J Clin.
59:366–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pero R, Lembo F, Palmieri EA, Vitiello C,
Fedele M, Fusco A, Bruni CB and Chiariotti L: PATZ attenuates the
RNF4-mediated enhancement of androgen receptor-dependent
transcription. J Biol Chem. 277:3280–3285. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fedele M, Benvenuto G, Pero R, Majello B,
Battista S, Lembo F, Vollono E, Day PM, Santoro M, Lania L, et al:
A novel member of the BTB/POZ family, PATZ, associates with the
RNF4 RING finger protein and acts as a transcriptional repressor. J
Biol Chem. 275:7894–7901. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mastrangelo T, Modena P, Tornielli S,
Bullrich F, Testi MA, Mezzelani A, Radice P, Azzarelli A, Pilotti
S, Croce CM, et al: A novel zinc finger gene is fused to EWS
in small round cell tumor. Oncogene. 19:3799–3804. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tian X, Sun D, Zhang Y, Zhao S, Xiong H
and Fang J: Zinc finger protein 278, a potential oncogene in human
colorectal cancer. Acta Biochim Biophys Sin. 40:289–296. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu R, Wang X, Chen ZF, Sun DF, Tian XQ and
Fang JY: Inhibition of the extracellular signal-regulated
kinase/mitogen-activated protein kinase pathway decreases DNA
methylation in colon cancer cells. J Biol Chem. 282:12249–12259.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ye X, Nalepa G, Welcker M, Kessler BM,
Spooner E, Qin J, Elledge SJ, Clurman BE and Harper JW: Recognition
of phosphodegron motifs in human cyclin E by the SCFFbw7
ubiquitin ligase. J Biol Chem. 279:50110–50119. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roberts PJ and Der CJ: Targeting the
Raf-MEK-ERK mitogen-activated protein kinase cascade for the
treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hong SK, Yoon S, Moelling C, Arthan D and
Park JI: Noncatalytic function of ERK1/2 can promote
Raf/MEK/ERK-mediated growth arrest signaling. J Biol Chem.
284:33006–33018. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Crews CM, Alessandrini A and Erikson RL:
The primary structure of MEK, a protein kinase that phosphorylates
the ERK gene product. Science. 258:478–480. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cowley S, Paterson H, Kemp P and Marshall
CJ: Activation of MAP kinase kinase is necessary and sufficient for
PC12 differentiation and for transformation of NIH 3T3 cells. Cell.
77:841–852. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sung JJ, Lau JY, Goh KL and Leung WK: Asia
Pacific Working Group on Colorectal Cancer: Increasing incidence of
colorectal cancer in Asia: Implications for screening. Lancet
Oncol. 6:871–876. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fodde R: The APC gene in colorectal
cancer. Eur J Cancer. 38:867–871. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rochlitz CF, Herrmann R and de Kant E:
Overexpression and amplification of c-myc during progression of
human colorectal cancer. Oncology. 53:448–454. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Abdollahi A, Pisarcik D, Roberts D,
Weinstein J, Cairns P and Hamilton TC: LOT1
(PLAGL1/ZAC1), the candidate tumor suppressor gene at
chromosome 6q24-25, is epigenetically regulated in cancer. J Biol
Chem. 278:6041–6049. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pourquié O: Developmental biology. A macho
way to make muscles. Nature. 409:679–680. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Purandare SM, Ware SM, Kwan KM, Gebbia M,
Bassi MT, Deng JM, Vogel H, Behringer RR, Belmont JW and Casey B: A
complex syndrome of left-right axis, central nervous system and
axial skeleton defects in Zic3 mutant mice. Development.
129:2293–2302. 2002.PubMed/NCBI
|
|
21
|
Yang JJ: A novel zinc finger protein,
ZZaPK, interacts with ZAK and stimulates the ZAK-expressing cells
re-entering the cell cycle. Biochem Biophys Res Commun. 301:71–77.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Valentino T, Palmieri D, Vitiello M,
Simeone A, Palma G, Arra C, Chieffi P, Chiariotti L, Fusco A and
Fedele M: Embryonic defects and growth alteration in mice with
homozygous disruption of the Patz1 gene. J Cell Physiol.
228:646–653. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chieffi P and Chieffi S: Molecular
biomarkers as potential targets for therapeutic strategies in human
testicular germ cell tumors: An overview. J Cell Physiol.
228:1641–1646. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chiappetta G, Valentino T, Vitiello M,
Pasquinelli R, Monaco M, Palma G, Sepe R, Luciano A, Pallante P,
Palmieri D, et al: PATZ1 acts as a tumor suppressor in thyroid
cancer via targeting p53-dependent genes involved in EMT and cell
migration. Oncotarget. 6:5310–5323. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ow JR, Ma H, Jean A, Goh Z, Lee YH, Chong
YM, Soong R, Fu XY, Yang H and Wu Q: Patz1 regulates embryonic stem
cell identity. Stem Cells Dev. 23:1062–1073. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tritz R, Mueller BM, Hickey MJ, Lin AH,
Gomez GG, Hadwiger P, Sah DW, Muldoon L, Neuwelt EA and Kruse CA:
siRNA Down-regulation of the PATZ1 gene in human glioma cells
increases their sensitivity to apoptotic stimuli. Cancer Ther.
6:865–876. 2008.PubMed/NCBI
|
|
27
|
Pero R, Palmieri D, Angrisano T, Valentino
T, Federico A, Franco R, Lembo F, Klein-Szanto AJ, Del Vecchio L,
Montanaro D, et al: POZ-, AT-hook-, and zinc finger-containing
protein (PATZ) interacts with human oncogene B cell lymphoma 6
(BCL6) and is required for its negative autoregulation. J Biol
Chem. 287:18308–18317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Keskin N, Deniz E, Eryilmaz J, Un M, Batur
T, Ersahin T, Atalay Cetin R, Sakaguchi S, Ellmeier W and Erman B:
PATZ1 is a DNA damage-responsive transcription factor that inhibits
p53 function. Mol Cell Biol. 35:1741–1753. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Valentino T, Palmieri D, Vitiello M,
Pierantoni GM, Fusco A and Fedele M: PATZ1 interacts with p53 and
regulates expression of p53-target genes enhancing apoptosis or
cell survival based on the cellular context. Cell Death Dis.
4:e9632013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cho JH, Kim MJ, Kim KJ and Kim JR: POZ/BTB
and AT-hook-containing zinc finger protein 1 (PATZ1) inhibits
endothelial cell senescence through a p53 dependent pathway. Cell
Death Differ. 19:703–712. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yan L, Gu H, Li J, Xu M, Liu T, Shen Y,
Chen B and Zhang G: RKIP and 14-3-3ε exert an opposite effect on
human gastric cancer cells SGC7901 by regulating the ERK/MAPK
pathway differently. Dig Dis Sci. 58:389–396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
De Luca A, Maiello MR, D'Alessio A,
Pergameno M and Normanno N: The RAS/RAF/MEK/ERK and the PI3K/AKT
signalling pathways: Role in cancer pathogenesis and implications
for therapeutic approaches. Expert Opin Ther Targets. 16 Suppl
2:S17–S27. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Levidou G, Saetta AA, Gigelou F, Karlou M,
Papanastasiou P, Stamatelli A, Kavantzas N, Michalopoulos NV,
Agrogiannis G, Patsouris E, et al: ERK/pERK expression and B-raf
mutations in colon adenocarcinomas: Correlation with
clinicopathological characteristics. World J Surg Oncol. 10:472012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Santarpia L, Lippman SM and El-Naggar AK:
Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy.
Expert Opin Ther Targets. 16:103–119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fang JY and Richardson BC: The MAPK
signalling pathways and colorectal cancer. Lancet Oncol. 6:322–327.
2005. View Article : Google Scholar : PubMed/NCBI
|
